The chart on pages 3 to 7 gives the reason for eac
Post# of 30027
The rest (694,713,662 shares) were issued in the merger described below:
"On April 4, 2019 (the "Closing Date", pursuant to an agreement and plan of merger agreement (the "Agreement", EMOR acquired 100% of the membership interests in Pura Vida Health, LLC (Pura Vida), in exchange for the issuance of 694,713,662 shares of EMOR common stock (the "Acquisition" to the members of Pura Vida ("Sellers", whereby Pura Vida became a wholly-owned subsidiary of EMOR (collectively EMOR and Pura Vida are defined as the "Company"."